Adam a Eva
Utorok, 24. decembra 2024
Zaujímavosti o referátoch
Hepatitída typu A a B
11.12.2009
jpet
Reagovať
mimoriadne bezpečná?
"... Vakcína vyvinutá na obranu pred vírusom hepatitída B je mimoriadne bezpečná a spoľahlivá... " - tak toto možno platí ak za vážnu chorobu nepovažuješ Sklerózu multiplex. Pravdepodobnosť jej rozvoja je asi 5,2x vyššia pre zaočkovaných ako pre nezaočkovaných. Pozri
1. Geier DA, Geier MR. A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 2005; 38:295-301
2. Hernan MA, Jick SS, Olek MJ, et al. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study. Neurology 2004; 63:838-842
3. Geier MR, Geier DA. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol 2004; 22:749-755
1. Geier DA, Geier MR. A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 2005; 38:295-301
2. Hernan MA, Jick SS, Olek MJ, et al. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study. Neurology 2004; 63:838-842
3. Geier MR, Geier DA. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol 2004; 22:749-755
12.12.2006
Lucia Zubová
Reagovať
OK!:) =) ;)tak dik!
Je to uplne dokonale a za tento referat som dostala zy1..tak dik!:)
